While initial results have been inconsistent, this represents an intriguing area for future research
Despite that the serious adverse events (SAE) were similar to semaglutide 1 mg, the AE leading to drug discontinuation were 1030% compared to 4% with semaglutide 1 mg (Table 3)
Rosenstock J, Fonseca VA, Gross JL, et al
The broader trend The insurance industry is slowly acknowledging that obesity is a chronic medical condition requiring treatment, not a lifestyle choice
CVOT trial will help determine if tirzepatide can demonstrate superior cardiovascular safety and potential additional cardiovascular benefits compared to the currently approved GLP-1RA dulaglutide
The two primary endpoints were the Kansas City Cardiomyopathy Questionnaire clinical summary score (KCCQ-CSS, which ranges from 0 to 100) and the Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS)